227 related articles for article (PubMed ID: 34297047)
1. Genomic and clinical characterization of early T-cell precursor lymphoblastic lymphoma.
Xu X; Paxton CN; Hayashi RJ; Dunsmore KP; Winter SS; Hunger SP; Winick NJ; Carroll WL; Loh ML; Devidas M; Gross TG; Bollard CM; Perkins SL; Miles RR
Blood Adv; 2021 Jul; 5(14):2890-2900. PubMed ID: 34297047
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of adult patients with early T-cell precursor (ETP) acute lymphoblastic leukemia/lymphoma (ALL) and non-ETP T-ALL.
Onishi Y; Furukawa E; Kamata M; Fukatsu M; Kameoka Y; Hatta S; Hamada H; Oyake T; Kai T; Sukegawa M; Nakajima S; Yanagiya R; Yamaguchi K; Takahashi T; Harazaki Y; Izumi T; Murai K; Ito S; Ikezoe T; Ishizawa K; Takahashi N; Harigae H
Int J Hematol; 2023 May; 117(5):738-747. PubMed ID: 36757523
[TBL] [Abstract][Full Text] [Related]
3. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype.
Jain N; Lamb AV; O'Brien S; Ravandi F; Konopleva M; Jabbour E; Zuo Z; Jorgensen J; Lin P; Pierce S; Thomas D; Rytting M; Borthakur G; Kadia T; Cortes J; Kantarjian HM; Khoury JD
Blood; 2016 Apr; 127(15):1863-9. PubMed ID: 26747249
[TBL] [Abstract][Full Text] [Related]
4. Early T-Cell Precursor Leukemia: A High-Risk Subtype of Acute Lymphoblastic Leukemia, Single Center Experience in Jordan.
Halahleh K; Muradi I; Khalil MZ; Halahleh L; Sughayer M; Kamal N; Sultan I; Alrabi K
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):e411-e419. PubMed ID: 37730482
[TBL] [Abstract][Full Text] [Related]
5. Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia.
Coustan-Smith E; Mullighan CG; Onciu M; Behm FG; Raimondi SC; Pei D; Cheng C; Su X; Rubnitz JE; Basso G; Biondi A; Pui CH; Downing JR; Campana D
Lancet Oncol; 2009 Feb; 10(2):147-56. PubMed ID: 19147408
[TBL] [Abstract][Full Text] [Related]
6. Early T-cell precursor leukemia: a subtype of high risk childhood acute lymphoblastic leukemia.
Ma M; Wang X; Tang J; Xue H; Chen J; Pan C; Jiang H; Shen S
Front Med; 2012 Dec; 6(4):416-20. PubMed ID: 23065427
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic analysis of T-acute lymphoblastic leukemia. A CD5-based ETP-ALL perspective of non-ETP T-ALL.
Chopra A; Bakhshi S; Pramanik SK; Pandey RM; Singh S; Gajendra S; Gogia A; Chandramohan J; Sharma A; Kumar L; Seth R; Rai S; Kumar R
Eur J Haematol; 2014 Mar; 92(3):211-8. PubMed ID: 24329989
[TBL] [Abstract][Full Text] [Related]
8. Childhood Early T Cell Precursor Acute Lymphoblastic Leukaemia with t(12;17) (p13;q21) Translocation - A Rare Entity or Part of ETP/Myeloid Mixed Phenotype Acute Leukaemia.
Krishnan Y; S G; Joy A; S SP; S RJ; S S
Gulf J Oncolog; 2022 Sep; 1(40):78-82. PubMed ID: 36448075
[TBL] [Abstract][Full Text] [Related]
9. Early T-Cell Precursor Leukemia Has a Higher Risk of Induction-Related Infection among T-Cell Acute Lymphoblastic Leukemia in Adult.
Huang K; Dai M; Li Q; Liu N; Lin D; Wang Q; Zhou X; Wang Z; Gao Y; Jin H; Liu X; Liu Q; Zhou H
Mediators Inflamm; 2020; 2020():8867760. PubMed ID: 33424437
[TBL] [Abstract][Full Text] [Related]
10. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia.
Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ
Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of JAK/STAT pathway inhibition in murine xenograft models of early T-cell precursor (ETP) acute lymphoblastic leukemia.
Maude SL; Dolai S; Delgado-Martin C; Vincent T; Robbins A; Selvanathan A; Ryan T; Hall J; Wood AC; Tasian SK; Hunger SP; Loh ML; Mullighan CG; Wood BL; Hermiston ML; Grupp SA; Lock RB; Teachey DT
Blood; 2015 Mar; 125(11):1759-67. PubMed ID: 25645356
[TBL] [Abstract][Full Text] [Related]
12. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of ETP phenotype and minimal residual disease in T-ALL: a Children's Oncology Group study.
Wood BL; Devidas M; Summers RJ; Chen Z; Asselin B; Rabin KR; Zweidler-McKay PA; Winick NJ; Borowitz MJ; Carroll WL; Raetz EA; Loh ML; Hunger SP; Dunsmore KP; Teachey DT; Winter SS
Blood; 2023 Dec; 142(24):2069-2078. PubMed ID: 37556734
[TBL] [Abstract][Full Text] [Related]
14. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy.
Khogeer H; Rahman H; Jain N; Angelova EA; Yang H; Quesada A; Ok CY; Sui D; Wei P; Al Fattani A; Pierce S; Loghavi S; Lamb A; Hu P; Thakral B; Kanagal-Shamanna R; Jorgensen JL; Jabbour EJ; Kantarjian HM; Medeiros LJ; Khoury JD
Br J Haematol; 2019 Aug; 186(4):538-548. PubMed ID: 31115909
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features and Prognosis According to Immunophenotypic Subtypes Including the Early T-Cell Precursor Subtype of T-Lymphoblastic Lymphoma in the Japanese Pediatric Leukemia/Lymphoma Study Group ALB-NHL03 Study.
Fukano R; Sunami S; Sekimizu M; Takimoto T; Mori T; Mitsui T; Mori T; Saito AM; Watanabe T; Ohshima K; Fujimoto J; Nakazawa A; Kiyokawa N; Kobayashi R; Horibe K; Tsurusawa M
J Pediatr Hematol Oncol; 2018 Jan; 40(1):e34-e37. PubMed ID: 28538509
[TBL] [Abstract][Full Text] [Related]
16. [Outcome of 126 adolescent and adult T-cell acute leukemia/lymphoma patients and the prognostic significance of early T-cell precursor leukemia subtype].
Liao HY; Sun ZY; Wang YX; Jin YM; Zhu HL; Jiang NG
Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):561-567. PubMed ID: 32397018
[No Abstract] [Full Text] [Related]
17. A Novel Case of Concurrent T-cell and Early T-cell Precursor Lymphoblastic Lymphoma in an Adolescent Female.
Treinen C; Abu-Arja MH; Kahwash SB; Rangarajan HG; Willen F; Audino AN
J Pediatr Hematol Oncol; 2022 Mar; 44(2):e550-e553. PubMed ID: 34310470
[TBL] [Abstract][Full Text] [Related]
18. Deletions of the long arm of chromosome 5 define subgroups of T-cell acute lymphoblastic leukemia.
La Starza R; Barba G; Demeyer S; Pierini V; Di Giacomo D; Gianfelici V; Schwab C; Matteucci C; Vicente C; Cools J; Messina M; Crescenzi B; Chiaretti S; Foà R; Basso G; Harrison CJ; Mecucci C
Haematologica; 2016 Aug; 101(8):951-8. PubMed ID: 27151989
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic and molecular characteristics and outcomes of adult patients with early T-cell precursor acute lymphoblastic leukemia.
Yoon JH; Kim HS; Min GJ; Park SS; Park S; Lee SE; Cho BS; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Lee JW; Kim M; Kim Y; Lee S
Eur J Haematol; 2023 Feb; 110(2):137-148. PubMed ID: 36217591
[TBL] [Abstract][Full Text] [Related]
20. Outcome of T-cell acute lymphoblastic leukemia/lymphoma: Focus on near-ETP phenotype and differential impact of nelarabine.
Morita K; Jain N; Kantarjian H; Takahashi K; Fang H; Konopleva M; El Hussein S; Wang F; Short NJ; Maiti A; Sasaki K; Garcia-Manero G; Konoplev S; Ravandi F; Khoury JD; Jabbour E
Am J Hematol; 2021 May; 96(5):589-598. PubMed ID: 33639000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
